14 results match your criteria: "Cardiovascular-Genetic Center[Affiliation]"

Background/objectives: Identifying novel variants in very rare disease genes can be challenging when patients exhibit a complex phenotype that expands the one described, and we provide such an example here. A few terminal truncating variants in cause spastic paraplegia (SP), intellectual disability (ID), nystagmus, and obesity (SINO, MIM #617296). Prompted by the result of next-generation sequencing on a patient referred for SP associated with complex brain dysmorphisms, we reviewed the phenotype of SINO patients focusing on their brain malformations, mainly described in prenatal age and first years of life, and tried to understand if the predicted effect of the mutant kidins220 may have caused them.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze self-care behaviors and self-care self-efficacy in Marfan syndrome patients while identifying factors influencing these behaviors.
  • It found that while patients performed adequately in maintaining health and monitoring symptoms, their management of symptoms when they occur was lacking.
  • The research emphasizes the need for improved educational programs to boost self-care management and self-efficacy in these patients, with recommendations for healthcare professionals to focus on targeted educational activities.
View Article and Find Full Text PDF
Article Synopsis
  • Marfan syndrome (MFS) is a rare genetic disorder that affects connective tissue, leading to serious complications like thoracic aortic aneurysms (TAA), which may require preventive surgery.
  • There is a need for non-invasive biomarkers and new therapeutic targets for MFS, as current monitoring methods involve complex imaging and are time-sensitive.
  • Recent studies using high-throughput platforms have identified potential biomarkers and therapeutic targets related to pathways involved in MFS, but further validation in large patient groups is needed to confirm their effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • Marfan syndrome (MFS) is a rare genetic disorder caused by mutations in the Fibrillin-1 gene, leading to various systemic issues, particularly affecting the cardiovascular, ocular, and musculoskeletal systems.
  • Accurate diagnosis is crucial for effective treatment and involves scoring systems and identifying DNA mutations to distinguish MFS from other connective tissue diseases.
  • A multidisciplinary team approach is recommended for managing MFS, incorporating specialists from various fields to ensure comprehensive care and personalized treatment for patients.
View Article and Find Full Text PDF
Article Synopsis
  • Vascular Ehlers-Danlos syndrome (vEDS) is a rare genetic disorder caused by mutations in a specific gene, leading to severe health issues.
  • Timely and accurate diagnosis is crucial for improving patient outcomes through targeted treatments, but the disease's variability makes diagnosis challenging.
  • A reported case highlights a patient with a new genetic variant who experienced severe complications, including aneurysms and ultimately died from pulmonary bleeding at 26 due to delayed genetic evaluation.
View Article and Find Full Text PDF

Although vaccine hesitancy has been reported in many patient groups and countries, there is a lack of data on vaccine hesitancy in patients with Marfan syndrome (MFS). MFS is a rare genetic disorder that can lead to cardiovascular, ocular, and musculoskeletal issues. Because MFS patients may face an increased risk of COVID-19 complications, vaccination is crucial for this population.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the mental health impacts, specifically PTSD, depression, anxiety, and insomnia, in patients with Marfan syndrome during the COVID-19 pandemic in Lombardy, Italy.
  • Approximately 10% of the 112 participants demonstrated concerning psychological symptoms, with PTSD primarily linked to higher anxiety levels, older age, use of psychoactive medications, and unemployment.
  • The findings highlight the need for ongoing mental health monitoring and the development of targeted psychosocial interventions for Marfan syndrome patients to address mental health challenges exacerbated by the pandemic.
View Article and Find Full Text PDF

(1) Background: Perivascular adipose tissue attenuation, measured with computed tomography imaging, is a marker of mean local vascular inflammation since it reflects the morphological changes of the fat tissue in direct contact with the vessel. This method is thoroughly validated in coronary arteries, but few studies have been performed in other vascular beds. The aim of the present study is to provide insight into the potential application of perivascular adipose tissue attenuation through computed tomography imaging in extra-coronary arteries.

View Article and Find Full Text PDF

Introduction: The structural validity and reliability of the Short-Form Health Survey 12 (SF-12) has not yet been tested in adults with the Marfan syndrome (MFS). This gap could undermine an evidence-grounded practice and research, especially considering that the need to assess health-related quality of life in patients with MFS has increased due to the improved life expectancy of these patients and the need to identify their determinants of quality of life. For this reason, this study aimed to confirm the dimensionality (structural validity) of the SF-12, its concurrent validity, and its reliability (internal consistency).

View Article and Find Full Text PDF

Background: The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was launched in 2017 and involves, to date, 35 highly specialised multidisciplinary expert centres (from the 30 full Healthcare Provider members) coming from 11 countries and more than 70 patient organizations from 16 countries. The eHealth Working Group (WG) of VASCERN was set up to develop practical, patient-centred solutions and strategies for effective use of eHealth tools to answer the needs of patients with multisystemic vascular rare diseases.

The Ehealth Wg: Following the identified patients' needs and following the guiding principles of collaboration and patient-centredness, the eHealth WG was created with the following aims: to develop a mobile app to help patients find expert centres and patient organizations, and to develop resources (Pills of Knowledge, PoK) for training and education via digital platforms (eLearning).

View Article and Find Full Text PDF

Background: Marfan's syndrome (MFS) seems to be frequently associated with colonic diverticulosis, but the prevalence of diverticula and symptoms evocative of diverticular disease in this population are still unknown.

Methods: This prospective case control study included 90 consecutive patients with MFS, 90 unselected controls, and 90 asymptomatic subjects. The clinical characteristics, including lower gastrointestinal symptoms, and ultrasonographic features of the bowel, including diverticula and thickening of the muscularis propria of the sigmoid colon, were investigated.

View Article and Find Full Text PDF

Marfan syndrome (MFS) is an autosomal genetic disorder of connective tissue, due to alterated fibrillin-1. The aim of our study was to verify the rate of fractures in children with MFS in correlation to bone mineral density and compare the prevalence to the general population in the same latitude. We enrolled 80 patients (37 girls and 43 boys) with the diagnosis of Marfan syndrome, median age 10 y (3 to 17 years).

View Article and Find Full Text PDF

Reply to letter to editor: "Genetic basis of dilated cardiomyopathy".

Int J Cardiol

February 2017

Cardiovascular Genetic Center, IDIBGI, University of Girona, Girona, Spain; Medical Science Department, School of Medecine, University of Girona, Spain.

View Article and Find Full Text PDF

Forensic medicine defines the unexplained sudden death as a death with a non-conclusive diagnosis after autopsy. Molecular diagnosis is being progressively incorporated in forensics, mainly due to improvement in genetics. New genetic technologies may help to identify the genetic cause of death, despite clinical interpretation of genetic data remains the current challenge.

View Article and Find Full Text PDF